Related Experiment Video
Updated: Jun 16, 2025

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Identifying cooperating cancer driver genes in individual patients through hypergraph random walk
Tong Zhang1, Shao-Wu Zhang2, Ming-Yu Xie2
1Key Laboratory of Information Fusion Technology of Ministry of Education, School of Automation, Northwestern Polytechnical University, Xi'an 710072, China; School of Electrical and Mechanical Engineering, Pingdingshan University, Pingdingshan 467000, China.
Identifying cooperating cancer driver genes is crucial for personalized cancer therapy. Our novel Personalized Cooperating cancer Driver Genes (PCoDG) method uses hypergraph random walks to find these genes, improving precision oncology.
Area of Science:
- Oncology
- Computational Biology
- Genomics
Background:
- Identifying cancer driver genes is essential for targeted cancer therapies.
- Current methods often overlook the cooperative interactions between driver genes.
- Understanding these cooperative relationships is key to personalized treatment strategies.
Purpose of the Study:
- To develop a novel method for identifying cooperating cancer driver genes at the individual patient level.
- To address the limitation of existing methods that focus on single genes.
- To advance the development of personalized cancer therapies by uncovering gene cooperation.
Main Methods:
- Proposed the Personalized Cooperating cancer Driver Genes (PCoDG) method.
- Utilized hypergraph random walk to model multi-way gene interactions within individual patients.
- Integrated gene mutation, expression data, and signaling pathway information to score gene importance.
Main Results:
- PCoDG effectively identified personalized cooperating cancer driver genes across three TCGA cancer datasets (BRCA, LUAD, COADREAD).
- The identified genes provide insights into patient stratification and clinical outcome correlations.
- Results offer a valuable resource for developing tailored cancer treatments.
Conclusions:
- The PCoDG method successfully identifies cooperating cancer driver genes for individual patients.
- This approach enhances understanding of the cooperative dynamics among personalized cancer driver genes.
- The findings contribute to the advancement of precision oncology and personalized medicine.
More Related Videos
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Survival Analysis